Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| IRPL2 | Q9NP60 | X-linked interleukin-1 receptor accessory protein-like 2 (IL-1 receptor accessory protein-like 2) (IL-1-RAPL-2) (IL-1RAPL-2) (IL1RAPL-2) (EC 3.2.2.6) (IL1RAPL-2-related protein) (Interleukin-1 receptor 9) (IL-1R-9) (IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1) (TIGIRR-1) | 1 | Other mediation | 4 | 0.50 | ||||
| ITB4 | P16144 | Integrin beta-4 (GP150) (CD antigen CD104) | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationReceptor-signaling mediation | 4 | 0.50 | |||
| KCJ13 | O60928 | Inward rectifier potassium channel 13 (Inward rectifier K(+) channel Kir7.1) (Potassium channel, inwardly rectifying subfamily J member 13) | 2 | Fusion and delivery mediation | 4 | 0.50 | ||||
| LRP11 | Q86VZ4 | Low-density lipoprotein receptor-related protein 11 (LRP-11) | 1 | Other mediation | 4 | 0.50 | ||||
| MDR3 | P21439 | Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3) | Disease related genesEnzymesHuman disease related genes | 12 | Acute myeloid leukaemiaBreast cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 4 | 0.50 | ||
| MOT8 | P36021 | Monocarboxylate transporter 8 (MCT 8) (Monocarboxylate transporter 7) (MCT 7) (Solute carrier family 16 member 2) (X-linked PEST-containing transporter) | 12 | Fusion and delivery mediation | 4 | 0.50 | ||||
| MTLR | O43193 | Motilin receptor (G-protein coupled receptor 38) | 7 | Bowel habit changeDigestive system diseaseDyspepsia | Clinical-translation mediationReceptor-signaling mediation | 4 | 0.50 | |||
| NEP | P08473 | Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | AsthmaCardiovascular diseaseChoreiform disorder | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 4 | 0.50 | ||
| PCDB4 | Q9Y5E5 | Protocadherin beta-4 (PCDH-beta-4) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 4 | 0.50 | |||
| PCDG4 | Q9Y5G9 | Protocadherin gamma-A4 (PCDH-gamma-A4) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 4 | 0.50 | |||
| PCDGJ | Q9Y5F8 | Protocadherin gamma-B7 (PCDH-gamma-B7) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 4 | 0.50 | |||
| PCDGK | Q9UN70 | Protocadherin gamma-C3 (PCDH-gamma-C3) (Protocadherin-2) (Protocadherin-43) (PC-43) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediation | 4 | 0.50 | |||
| PD2R | Q13258 | Prostaglandin D2 receptor (PGD receptor) (PGD2 receptor) (Prostanoid DP receptor) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | Allergic/hypersensitivity disorderArterial occlusive diseaseAsthma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 4 | 0.50 | ||
| PK2L1 | Q9P0L9 | Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog) (Polycystin-L) (Polycystin-L1) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 6 | Fusion and delivery mediation | 4 | 0.50 | |||
| SCNNG | P51170 | Epithelial sodium channel subunit gamma (ENaC subunit gamma) (ENaCG) (Epithelial Na(+) channel subunit gamma) (Gamma-ENaC) (Amiloride-sensitive sodium channel subunit gamma) (Gamma-NaCH) (Nonvoltage-gated sodium channel 1 subunit gamma) (SCNEG) (Sodium channel epithelial 1 subunit gamma) | 2 | Fusion and delivery mediationMetabolism mediation | 4 | 0.50 | ||||
| SLAF6 | Q96DU3 | SLAM family member 6 (Activating NK receptor) (NK-T-B-antigen) (NTB-A) (CD antigen CD352) | CD markersPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 4 | 0.50 | |||
| SORC1 | Q8WY21 | VPS10 domain-containing receptor SorCS1 (hSorCS) | Predicted membrane proteinsTransporters | 1 | Receptor-signaling mediation | 4 | 0.50 | |||
| SRPRB | Q9Y5M8 | Signal recognition particle receptor subunit beta (SR-beta) (Protein APMCF1) | Essential proteinsPredicted membrane proteins | 1 | Metabolism mediation | 4 | 0.50 | |||
| TM108 | Q6UXF1 | Transmembrane protein 108 (Retrolinkin) | Predicted intracellular proteinsPredicted membrane proteins | 2 | Adhesion and uptake mediationFusion and delivery mediation | 4 | 0.50 | |||
| TM2D2 | Q9BX73 | TM2 domain-containing protein 2 (Beta-amyloid-binding protein-like protein 1) (BBP-like protein 1) | Predicted intracellular proteinsPredicted membrane proteins | 2 | Other mediation | 4 | 0.50 | |||
| TMC5 | Q6UXY8 | Transmembrane channel-like protein 5 | Predicted membrane proteinsTransporters | 10 | Other mediation | 4 | 0.50 | |||
| TNR21 | O75509 | Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358) | CD markersPlasma proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationImmune mediationMetabolism mediation | 4 | 0.50 | |||
| TNR9 | Q07011 | Tumor necrosis factor receptor superfamily member 9 (4-1BB ligand receptor) (CDw137) (T-cell antigen 4-1BB homolog) (T-cell antigen ILA) (CD antigen CD137) | 1 | Fusion and delivery mediationImmune mediation | 4 | 0.50 | ||||
| TSN5 | P62079 | Tetraspanin-5 (Tspan-5) (Tetraspan NET-4) (Transmembrane 4 superfamily member 9) | 4 | Clinical-translation mediationMetabolism mediation | 4 | 0.50 | ||||
| AA2AR | P29274 | Adenosine receptor A2a | Cancer-related genesFDA approved drug targetsG-protein coupled receptors | 7 | Alzheimer diseaseArterial occlusive diseaseChoreiform disorder | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.50 |